The Cancer Letter

The Cancer Letter The Cancer Letter is an award-winning weekly newsletter covering cancer research funding, legislation, policy issues, drug development, cancer centers, and advocacy.
https://cancerletter.com/about-tcl/

The Cancer Letter, a weekly online publication, is the leading source of information on development of cancer therapies, cancer research funding and health care finance, legislation and policy. The Cancer Letter reaches the key opinion leaders in academic oncology and in the biotechnology and pharmaceutical industries. Our audience includes faculty and staff members at cancer centers, pharmaceutical and biotechnology companies, government agencies, and Wall Street professionals. Based in Washington, D.C., The Cancer Letter provides in-depth coverage of events at cancer centers, the National Cancer Institute, National Institutes of Health, Food & Drug Administration, U.S. Congress and the pharmaceutical industry. Over the past four decades, The Cancer Letter has earned acclaim and numerous journalism awards for its investigative coverage of issues that shape oncology. Our work has been profiled and cited in The New York Times, The Washington Post, 60 Minutes, 20/20, CNN, NPR, Science, Nature and many other news outlets. Our coverage has triggered investigations by Congressional committees, the Institute of Medicine, the Federal Trade Commission, the Securities and Exchange Commission, and the Department of Justice. The Cancer Letter was founded in 1973 by journalist Jerry D. Boyd, two years after Congress passed the National Cancer Act of 1971. Boyd retired in 1990, turning over the company to his daughter Kirsten Boyd Goldberg, who served as editor and publisher for the next 20 years. Paul Goldberg became publisher in January 2011.

Mission: The Cancer Letter provides fair and balanced coverage of events in oncology.

(Social + geographic) distance = Ongoing challenges in disparities for rural #cancer patients. Guest editorial by Heartl...
07/09/2020

(Social + geographic) distance = Ongoing challenges in disparities for rural #cancer patients. Guest editorial by Heartland Cancer Research NCORP's Jennifer Dill, Marsha Kutter, and Peggy Wisher. http://cancerletter.com/articles/20200702_4/

The NCI Board of Scientific Advisors has approved nine new and reissue concepts—Request for Applications, Cooperative Ag...
07/07/2020

The NCI Board of Scientific Advisors has approved nine new and reissue concepts—Request for Applications, Cooperative Agreement, Request for Proposals, and Program Announcements with special receipt, referral and review. http://cancerletter.com/articles/20200702/

Guest editorial by Friends of Cancer Research's Allen & Reagan-Udall Foundation for the FDA's Winckler: To expedite prog...
07/02/2020

Guest editorial by Friends of Cancer Research's Allen & Reagan-Udall Foundation for the FDA's Winckler: To expedite progress against #COVID19, a public-private “accelerator” taps into #RealWorldData — cancerletter.com/articles/20200626_5/

National Cancer Institute seeks applications to build research capacity for #COVID19 serology and immunology. #COVIDnCan...
07/01/2020

National Cancer Institute seeks applications to build research capacity for #COVID19 serology and immunology. #COVIDnCancer — cancerletter.com/articles/20200626_3/

American Association for Cancer Research (AACR) session on disparities points to the new consensus: Being woke is not en...
06/30/2020

American Association for Cancer Research (AACR) session on disparities points to the new consensus: Being woke is not enough.

The name of the session was a message in and of itself: “Racism and Racial Inequalities in Cancer Research."

Read more: http://cancerletter.com/articles/20200626_2/

Mobile pharmacies—driving down rural #cancer care disparities. Guest editorial by Cancer Care Specialists of Illinois."P...
06/25/2020

Mobile pharmacies—driving down rural #cancer care disparities. Guest editorial by Cancer Care Specialists of Illinois.

"People living in rural communities are often located far away from the major cancer centers that offer a full spectrum of treatments, including clinical trials." A first-of-its-kind mobile pharmacy seeks to change that.

Read more: http://cancerletter.com/articles/20200619_6/

Conquest of #COVID19: Publish it to death? We are publishing at a rate of "1 publication for every 4 daily deaths from C...
06/24/2020

Conquest of #COVID19: Publish it to death?
We are publishing at a rate of "1 publication for every 4 daily deaths from COVID-19 in the U.S.—and this is only for citations covered by PubMed," writes Robert Peter Gale. — http://cancerletter.com/articles/20200619_3/

American Cancer Society faces precipitous drop in fundraising. Uncertainty surrounds fall round of grants. — cancerlette...
06/23/2020

American Cancer Society faces precipitous drop in fundraising. Uncertainty surrounds fall round of grants. — cancerletter.com/articles/20200619_2/

National Cancer Institute's Sharpless: #COVID19 expected to increase mortality by at least 10,000 deaths from breast and...
06/22/2020

National Cancer Institute's Sharpless: #COVID19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years - #COVIDnCancer - http://cancerletter.com/articles/20200619_1/

.@ASCO data will provide actionable insights from the #COVID19 pandemic—for every patient. Guest editorial by @rschilsky...
06/18/2020

[email protected] data will provide actionable insights from the #COVID19 pandemic—for every patient. Guest editorial by @rschilsky — cancerletter.com/articles/20200605/

The Cancer Letter received five 2020 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Jo...
06/17/2020

The Cancer Letter received five 2020 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists — 3 first place and 2 finalists. http://cancerletter.com/articles/20200612_12/

Katie Goldberg's illustrations of #ASCO2019 won first place for Art/Photo Illustration. Since #ASCO2020 was virtual, we invite you to traipse down the halls of memory with this collection of her work:

As screening declines amid #COVID19, at-home stool DNA test for CRC gets high adherence in Medicare population. Guest ed...
06/17/2020

As screening declines amid #COVID19, at-home stool DNA test for CRC gets high adherence in Medicare population. Guest editorial by Exact Sciences CMO for screening, Paul J. Limburg. — http://cancerletter.com/articles/20200612_9/

David C. Fajgenbaum gained insight into #COVID19 while seeking treatment for Castleman disease (which he has) — cancerle...
06/16/2020

David C. Fajgenbaum gained insight into #COVID19 while seeking treatment for Castleman disease (which he has) — cancerletter.com/articles/20200612_4/

"I knew I wouldn’t make it to our wedding day unless I found a drug to keep me in remission, so I dove headfirst into research," Fajgenbaum said at the #ASCO20 opening session. "At this stage, I had failed to respond to all drugs that had ever been given to patients with my disease, and I began searching for a novel approach."

BTK inhibitors improve #COVID19 outcomes by targeting upstream switch for inflammation, early data suggest. Conversation...
06/16/2020

BTK inhibitors improve #COVID19 outcomes by targeting upstream switch for inflammation, early data suggest. Conversation with Wyndham Wilson & Louis Staudt: — cancerletter.com/articles/20200612_3/

Johns Hopkins Kimmel Cancer Center
06/15/2020
Johns Hopkins Kimmel Cancer Center

Johns Hopkins Kimmel Cancer Center

“I’m thrilled that doctors are concerned about health disparities, but we need to get at the social root of the cause. And we need to tackle all aspects of the health disparities problem—including, why is it that American society has created this ‘thing?’” Otis Brawley, Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University said to The Cancer Letter.

#WhiteCoats4BlackLives aims to lead to real change in #oncology. “I’ve never been more hopeful in my entire life.” — can...
06/15/2020

#WhiteCoats4BlackLives aims to lead to real change in #oncology. “I’ve never been more hopeful in my entire life.” — cancerletter.com/articles/20200612_2/

A movement that began with a fatal chokehold on a Minneapolis street grew into demands for police reform, but outrage didn’t stop there. Amplifying, reverberating, it became a call for racial justice in medicine, in oncology.

MD Anderson's Peter WT Pisters: Working to end #cancer in the time of #COVID19. — http://cancerletter.com/articles/20200...
06/15/2020

MD Anderson's Peter WT Pisters: Working to end #cancer in the time of #COVID19. — http://cancerletter.com/articles/20200612_1/

"When a novel virus is introduced to the human species, the world is changed forever," writes Pisters (MD Anderson Cancer Center).

Fostering a culture of gender-based respect and inclusion in oncology. Guest editorial by Narjust Duma, Christina Chapma...
06/10/2020

Fostering a culture of gender-based respect and inclusion in oncology.
Guest editorial by Narjust Duma, Christina Chapman, Stephanie Graff, Tatiana Prowell, Miriam Knoll — cancerletter.com/articles/20200605_7/

ASCO's Clifford Hudis: What a virtual meeting can accomplish—and what a virtual meeting cannot accomplish— cancerletter....
06/09/2020

ASCO's Clifford Hudis: What a virtual meeting can accomplish—and what a virtual meeting cannot accomplish— cancerletter.com/articles/20200605_6/
#ASCO20

States with Medicaid expansion have lower overall cancer mortality, study finds. No additional decrease observed in blac...
06/09/2020

States with Medicaid expansion have lower overall cancer mortality, study finds. No additional decrease observed in black populations because of worse baseline. — cancerletter.com/articles/20200605_5/

Here is what #cancer groups say about police brutality and health disparities: http://cancerletter.com/articles/20200605...
06/08/2020

Here is what #cancer groups say about police brutality and health disparities: http://cancerletter.com/articles/20200605_3/
NIH, NCI, FDA Oncology, ASCO, and others have released statements condemning racism.

"I could have been George Floyd" — Oncologists Robert Winn & Otis Brawley reflect on the cancer of racism. Winn: I am al...
06/08/2020

"I could have been George Floyd" — Oncologists Robert Winn & Otis Brawley reflect on the cancer of racism.

Winn: I am almost certain that no other director of an NCI-designated cancer center can claim the distinction of having had a gun pulled on them by police.

Brawley: Even a 40-plus-year-old military officer and physician can get thrown to the ground, handcuffed and questioned at gunpoint for looking suspicious in a nice part of Montgomery County. That would be yours truly a few years ago.

http://cancerletter.com/articles/20200605/

How Moffitt will heal from conflict of interest trauma—and from #COVID19. "Given the press, the leadership changes that ...
06/04/2020

How Moffitt will heal from conflict of interest trauma—and from #COVID19.

"Given the press, the leadership changes that were associated with problems with the Thousand Talents Program, and then COVID-19, we’re working very hard to make sure that all of our team members understand that inclusion is at our foundation."

The Cancer Letter spoke with Moffitt Cancer Center's John Cleveland: cancerletter.com/articles/20200529_4/

ASTRO survey data show #RadOnc appointments have decreased by about a third. Why? "There are certain feeder cancers that...
06/03/2020

ASTRO survey data show #RadOnc appointments have decreased by about a third. Why? "There are certain feeder cancers that keep the radiation oncology units busy. Those need to be diagnosed as a process. That process was broken—is broken," America Cancer Society's Len Lichtenfeld said.

cancerletter.com/articles/20200529_3/

Dr. Otis Brawley reviews the #CCC19 #ASCO20 data: "A most disturbing finding is that 40% of the 928 (371) patients in th...
06/02/2020

Dr. Otis Brawley reviews the #CCC19 #ASCO20 data: "A most disturbing finding is that 40% of the 928 (371) patients in the cohort were taking hydroxychloroquine, azithromycin, or both, and only two did so while enrolled on a clinical trial of these drugs."

Read his guest editorial: cancerletter.com/articles/20200529_2/

Ramon Parsons: How Mount Sinai Tisch Cancer Institute did good science amid the #COVID19 deluge. — cancerletter.com/arti...
06/01/2020

Ramon Parsons: How Mount Sinai Tisch Cancer Institute did good science amid the #COVID19 deluge. — cancerletter.com/articles/20200529_1/

A telesitevisit: Cancer center site visits go virtual amid #COVID19 pandemic. Adapting to COVID-19 travel bans, National...
05/28/2020

A telesitevisit: Cancer center site visits go virtual amid #COVID19 pandemic. Adapting to COVID-19 travel bans, National Cancer Institute has moved site visits online. — http://cancerletter.com/articles/20200522_5/

How Sylvester Comprehensive Cancer Center’s cancer outreach is used to monitor #COVID19 in Miami-Dade. "In this unpreced...
05/27/2020

How Sylvester Comprehensive Cancer Center’s cancer outreach is used to monitor #COVID19 in Miami-Dade.

"In this unprecedented COVID situation, we have had to marry need with opportunity," said Sylvester's Dr. Erin N. Kobetz.

Read more: http://cancerletter.com/articles/20200522_4/

Funerals, church choirs, poultry plants fuel #COVID19 in rural Georgia—threatening Atlanta with a second spike. — cancer...
05/26/2020

Funerals, church choirs, poultry plants fuel #COVID19 in rural Georgia—threatening Atlanta with a second spike. — cancerletter.com/articles/20200522_3/

Let’s not form blue ribbon panels to study disparities in #COVID19 deaths—Instead, let’s find the will to act.— Guest ed...
05/25/2020

Let’s not form blue ribbon panels to study disparities in #COVID19 deaths—Instead, let’s find the will to act.
— Guest editorial by VCU Massey Cancer Center's Rob Winn & Katherine Tossas.

"The surprise among government leaders and the media regarding COVID-19 disparities is a symptom of a more powerful, endemic virus that always lurks beneath the surface: the virus of denial."

Read more: http://cancerletter.com/articles/20200522_1/

CCC19 bridging the knowledge gap for patients with #COVID19 and cancer. First results to be heart at 2020 ASCO Annual Me...
05/25/2020

CCC19 bridging the knowledge gap for patients with #COVID19 and cancer. First results to be heart at 2020 ASCO Annual Meeting (#ASCO20). — cancerletter.com/articles/20200522_2/

Address

The Cancer Letter Inc, PO Box 9905
Washington D.C., DC
20016

Alerts

Be the first to know and let us send you an email when The Cancer Letter posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Cancer Letter:

Nearby media companies